Mitchell Stephen Ray 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 14, 2022
Insider Transaction Report
Form 4
Mitchell Stephen Ray
Director
Transactions
- Sale
Common Stock
2022-06-13$9.48/sh−2,700$25,593→ 6,515 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.431 to $9.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.